Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Pauls Dietrich John | President and CEO | 14 | $88.4K | $0 | 2026-08-10 |
| Semba Charles Pauling | Director | 11 | $50.0K | $0 | 2026-06-01 |
| Parsons James T. | Director | 18 | $9.0K | $0 | 2026-06-01 |
| Giuffre Randall Michael | Director | 31 | $560.2K | $0 | 2026-06-01 |
| Krop Julie | Chief Medical Officer | 2 | $0 | $0 | 2026-06-01 |
| Kellen Scott | CFO and Secretary | 14 | $103.0K | $0 | 2026-06-01 |
| Lewis Tanya | Director | 5 | $0 | $0 | 2026-06-01 |
| O'Connor Daniel J. | Director | 2 | $0 | $0 | 2026-06-01 |
| Kuntz Richard | Director | 6 | $0 | $0 | 2026-06-01 |
| TRILL AB | 10% Owner | 7 | $7.63M | $0 | 2025-11-25 |
| STAHLBERG JAN | 10% Owner | 11 | $14.36M | $0 | 2025-08-27 |
| Von Koch Thomas | 10% Owner | 3 | $13.54M | $3.54M | 2025-07-23 |
| JACINTO RICHARD II | 10% Owner | 1 | $1.40M | $0 | 2025-07-23 |
| Wambeke David J. | Chief Business Officer | 6 | $949.2K | $0 | 2025-06-01 |
| Pilnik Richard D. | Director | 23 | $399.6K | $0 | 2025-04-07 |
| TomEqt Private AB | 10% Owner | 2 | $8.00M | $0 | 2024-06-28 |
| Cundari Dominic R | Chief Commercial Officer | 4 | $0 | $0 | 2024-06-01 |
| Lorianne Masuoka K. | Chief Medical Officer | 1 | $0 | $0 | 2024-01-22 |
| Daves Julie VanOrsdel | SVP Clinical Development Oper. | 2 | $0 | $0 | 2023-06-01 |
| Gruis Kirsten L | Chief Medical Officer | 2 | $0 | $0 | 2023-06-01 |
| Burroughs Amy L. | Director | 5 | $141.6K | $0 | 2023-01-03 |
| TomEnterprise AB | 10% Owner | 1 | $276.6K | $0 | 2022-07-08 |
| ALCORN HARRY W JR | Senior VP, Clinical Operations | 11 | $145.1K | $0 | 2021-09-15 |
| Gilman Sydney A. | VP, Regulatory Affairs | 3 | $0 | $0 | 2021-07-28 |
| Xiao Zhenyu | Director, 10% Owner | 2 | $13.0K | $0 | 2019-06-24 |
| Verdoorn Todd A. | Chief Scientific Officer | 2 | $4.0K | $0 | 2019-06-24 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Pauls Dietrich John | President & CEO | A Award | 2026-08-10 | 2026-08-12 | 60,200 | — | $0 | 128,791 | SEC↗ |
| Pauls Dietrich John | President & CEO, Director | A Award | 2026-08-10 | 2026-08-12 | 60,200 | — | $0 | 128,791 | SEC↗ |
| Krop Julie | Chief Medical Officer | A Award deriv | 2026-06-01 | 2026-06-03 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Kellen Scott | CFO & Secretary | A Award deriv | 2026-06-01 | 2026-06-03 | 162,000 | — | $0 | 162,000 | SEC↗ |
| Pauls Dietrich John | President & CEO | A Award deriv | 2026-06-01 | 2026-06-03 | 380,000 | — | $0 | 380,000 | SEC↗ |
| Parsons James T. | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 51,189 | — | $0 | 51,189 | SEC↗ |
| Semba Charles Pauling | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 40,412 | — | $0 | 40,412 | SEC↗ |
| Lewis Tanya | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 40,412 | — | $0 | 40,412 | SEC↗ |
| O'Connor Daniel J. | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 40,412 | — | $0 | 40,412 | SEC↗ |
| Kuntz Richard | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 40,412 | — | $0 | 40,412 | SEC↗ |
| Giuffre Randall Michael | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 40,412 | — | $0 | 40,412 | SEC↗ |
| Semba Charles Pauling | Director | A Award | 2026-01-02 | 2026-01-06 | 3,355 | $8.42 | $28.2K | 47,963 | SEC↗ |
| Giuffre Randall Michael | Director | A Award | 2026-01-02 | 2026-01-06 | 6,175 | $8.42 | $52.0K | 398,587 | SEC↗ |
| Parsons James T. | Director | A Award | 2026-01-02 | 2026-01-06 | 10,095 | $8.42 | $85.0K | 97,949 | SEC↗ |
| TRILL AB | 10% Owner | P Buy | 2025-11-25 | 2025-12-08 | 73,099 | $8.57 | $626.5K | 8,825,742 | SEC↗ |
| TRILL AB | 10% Owner | P Buy | 2025-11-24 | 2025-12-08 | 40,253 | $7.89 | $317.6K | 8,752,643 | SEC↗ |
| Parsons James T. | Director | M Exercise deriv | 2025-11-21 | 2025-11-25 | 12,000 | — | $0 | 0 | SEC↗ |
| Parsons James T. | Director | M Exercise | 2025-11-21 | 2025-11-25 | 12,000 | $2.20 | $26.4K | 87,854 | SEC↗ |
| TRILL AB | 10% Owner | P Buy | 2025-11-21 | 2025-12-08 | 208,872 | $7.41 | $1.55M | 8,712,390 | SEC↗ |
| TRILL AB | 10% Owner | P Buy | 2025-11-20 | 2025-12-08 | 128,426 | $7.41 | $951.6K | 8,503,518 | SEC↗ |
| TRILL AB | 10% Owner | P Buy | 2025-11-19 | 2025-12-08 | 240,352 | $7.21 | $1.73M | 8,375,092 | SEC↗ |
| TRILL AB | 10% Owner | P Buy | 2025-11-18 | 2025-12-08 | 182,882 | $6.75 | $1.23M | 8,134,740 | SEC↗ |
| TRILL AB | 10% Owner | P Buy | 2025-11-17 | 2025-12-08 | 187,393 | $6.52 | $1.22M | 7,951,858 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2025-08-27 | 2025-09-04 | 50,772 | $6.00 | $304.6K | 7,764,465 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2025-08-26 | 2025-09-04 | 59,648 | $6.00 | $357.9K | 7,713,693 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2025-08-25 | 2025-09-04 | 338,265 | $6.00 | $2.03M | 7,654,045 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2025-08-22 | 2025-09-04 | 59,788 | $5.96 | $356.3K | 7,315,780 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2025-08-21 | 2025-09-04 | 48,172 | $5.96 | $287.1K | 7,255,992 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2025-08-20 | 2025-09-04 | 71,107 | $5.86 | $416.7K | 7,207,820 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2025-08-15 | 2025-09-04 | 8,233 | $6.00 | $49.4K | 7,136,713 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2025-08-14 | 2025-09-04 | 70,414 | $5.99 | $421.8K | 7,128,480 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2025-08-13 | 2025-09-04 | 293,601 | $5.91 | $1.74M | 7,058,066 | SEC↗ |
| Krop Julie | Chief Marketing Officer | A Award deriv | 2025-08-11 | 2025-11-03 | 450,000 | — | $0 | 450,000 | SEC↗ |
| JACINTO RICHARD II | 10% Owner | P Buy | 2025-07-23 | 2025-07-25 | 400,000 | $3.50 | $1.40M | 4,958,823 | SEC↗ |
| Von Koch Thomas | 10% Owner | P Buy | 2025-07-23 | 2025-07-25 | 2,857,142 | $3.50 | $10.00M | 8,383,577 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2025-07-23 | 2025-07-25 | 1,542,857 | $3.50 | $5.40M | 6,764,465 | SEC↗ |
| Giuffre Randall Michael | Director | A Award deriv | 2025-06-01 | 2025-06-03 | 32,162 | — | $0 | 32,162 | SEC↗ |
| Kellen Scott | CFO & Secretary | A Award deriv | 2025-06-01 | 2025-06-03 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Kuntz Richard | Director | A Award deriv | 2025-06-01 | 2025-06-03 | 32,162 | — | $0 | 32,162 | SEC↗ |
| Lewis Tanya | Director | A Award deriv | 2025-06-01 | 2025-06-03 | 32,162 | — | $0 | 32,162 | SEC↗ |
| Parsons James T. | Director | A Award deriv | 2025-06-01 | 2025-06-03 | 40,739 | — | $0 | 40,739 | SEC↗ |
| Pauls Dietrich John | President & CEO | A Award deriv | 2025-06-01 | 2025-06-03 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Semba Charles Pauling | Director | A Award deriv | 2025-06-01 | 2025-06-03 | 32,162 | — | $0 | 32,162 | SEC↗ |
| Wambeke David J. | Chief Business Officer | A Award deriv | 2025-06-01 | 2025-06-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Pilnik Richard D. | Director | M Exercise deriv | 2025-04-07 | 2025-04-08 | 24,000 | — | $0 | 0 | SEC↗ |
| Pilnik Richard D. | Director | M Exercise | 2025-04-07 | 2025-04-08 | 24,000 | $2.11 | $50.6K | 312,995 | SEC↗ |
| O'Connor Daniel J. | Director | A Award deriv | 2025-02-20 | 2025-02-24 | 64,242 | — | $0 | 64,242 | SEC↗ |
| Giuffre Randall Michael | Director | M Exercise deriv | 2025-02-13 | 2025-02-18 | 5,000 | — | $0 | 0 | SEC↗ |
| Giuffre Randall Michael | Director | M Exercise deriv | 2025-02-13 | 2025-02-18 | 12,000 | — | $0 | 0 | SEC↗ |
| Giuffre Randall Michael | Director | M Exercise | 2025-02-13 | 2025-02-18 | 5,000 | $3.65 | $18.3K | 392,412 | SEC↗ |
| Giuffre Randall Michael | Director | M Exercise | 2025-02-13 | 2025-02-18 | 12,000 | $2.11 | $25.3K | 387,412 | SEC↗ |
| Parsons James T. | Director | A Award deriv | 2025-01-02 | 2025-01-03 | 4,287 | — | $0 | 4,287 | SEC↗ |
| Semba Charles Pauling | Director | A Award | 2025-01-02 | 2025-01-03 | 5,290 | $5.34 | $28.2K | 44,608 | SEC↗ |
| Pilnik Richard D. | Director | A Award | 2025-01-02 | 2025-01-03 | 10,393 | $5.34 | $55.5K | 288,995 | SEC↗ |
| Kuntz Richard | Director | A Award | 2025-01-02 | 2025-01-03 | 9,925 | $5.34 | $53.0K | 24,210 | SEC↗ |
| Giuffre Randall Michael | Director | A Award | 2025-01-02 | 2025-01-03 | 10,861 | $5.34 | $58.0K | 375,412 | SEC↗ |
| Parsons James T. | Director | A Award | 2025-01-02 | 2025-01-03 | 15,917 | $5.34 | $85.0K | 75,854 | SEC↗ |
| STAHLBERG JAN | 10% Owner | P Buy | 2024-06-28 | 2024-07-01 | 1,200,000 | $2.50 | $3.00M | 5,221,608 | SEC↗ |
| TomEnterprise Private AB | 10% Owner | P Buy | 2024-06-28 | 2024-07-01 | 1,200,000 | $2.50 | $3.00M | 5,526,435 | SEC↗ |
| Giuffre Randall Michael | Director | A Award deriv | 2024-06-01 | 2024-06-03 | 28,472 | — | $0 | 28,472 | SEC↗ |
| Kuntz Richard | Director | A Award deriv | 2024-06-01 | 2024-06-03 | 28,472 | — | $0 | 28,472 | SEC↗ |
| Lewis Tanya | Director | A Award deriv | 2024-06-01 | 2024-06-03 | 28,472 | — | $0 | 28,472 | SEC↗ |
| Parsons James T. | Director | A Award deriv | 2024-06-01 | 2024-06-03 | 28,472 | — | $0 | 28,472 | SEC↗ |
| Pilnik Richard D. | Director | A Award deriv | 2024-06-01 | 2024-06-03 | 36,065 | — | $0 | 36,065 | SEC↗ |
| Semba Charles Pauling | Director | A Award deriv | 2024-06-01 | 2024-06-03 | 28,472 | — | $0 | 28,472 | SEC↗ |
| Pauls Dietrich John | President and CEO | A Award deriv | 2024-06-01 | 2024-06-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Cundari Dominic R | Chief Commercial Officer | A Award deriv | 2024-06-01 | 2024-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kellen Scott | CFO and Secretary | A Award deriv | 2024-06-01 | 2024-06-03 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Wambeke David J. | Chief Business Officer | A Award deriv | 2024-06-01 | 2024-06-03 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Lorianne Masuoka K. | Chief Medical Officer | A Award deriv | 2024-01-22 | 2024-01-23 | 285,000 | — | $0 | 285,000 | SEC↗ |
| Giuffre Randall Michael | Director | A Award | 2024-01-02 | 2024-01-02 | 19,196 | $2.80 | $53.7K | 364,551 | SEC↗ |
| Parsons James T. | Director | A Award | 2024-01-02 | 2024-01-02 | 21,428 | $2.80 | $60.0K | 59,937 | SEC↗ |
| Pilnik Richard D. | Director | A Award | 2024-01-02 | 2024-01-02 | 30,357 | $2.80 | $85.0K | 278,602 | SEC↗ |
| Kuntz Richard | Director | A Award | 2024-01-02 | 2024-01-02 | 14,285 | $2.80 | $40.0K | 14,285 | SEC↗ |
| Semba Charles Pauling | Director | A Award | 2024-01-02 | 2024-01-02 | 9,375 | $2.80 | $26.3K | 39,318 | SEC↗ |
| Wambeke David J. | Chief Business Officer | P Buy | 2023-11-16 | 2023-11-16 | 20,000 | $2.46 | $49.2K | 527,114 | SEC↗ |
| Pilnik Richard D. | Director | P Buy | 2023-06-23 | 2023-06-26 | 38,363 | $3.91 | $150.0K | 248,245 | SEC↗ |
| Wambeke David J. | Chief Business Officer | P Buy | 2023-06-23 | 2023-06-26 | 38,364 | $3.91 | $150.0K | 507,114 | SEC↗ |
| Kellen Scott | CFO and Secretary | P Buy | 2023-06-23 | 2023-06-26 | 10,000 | $3.91 | $39.1K | 32,290 | SEC↗ |
| Semba Charles Pauling | Director | P Buy | 2023-06-23 | 2023-06-26 | 12,787 | $3.91 | $50.0K | 29,943 | SEC↗ |
| Pauls Dietrich John | President and CEO | P Buy | 2023-06-23 | 2023-06-26 | 12,787 | $3.91 | $50.0K | 68,591 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2023-06-23 | 2023-06-26 | 65,000 | $3.91 | $254.2K | 360,355 | SEC↗ |
| Giuffre Randall Michael | Director | G Gift | 2023-06-23 | 2023-06-26 | 15,000 | — | $0 | 345,355 | SEC↗ |
| TomEqt Private AB | 10% Owner | P Buy | 2023-06-23 | 2023-06-27 | 1,470,588 | $3.40 | $5.00M | 4,326,435 | SEC↗ |
| Giuffre Randall Michael | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 16,968 | — | $0 | 16,968 | SEC↗ |
| Lewis Tanya | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 7,493 | — | $0 | 7,493 | SEC↗ |
| Parsons James T. | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 16,968 | — | $0 | 16,968 | SEC↗ |
| Pilnik Richard D. | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 22,355 | — | $0 | 22,355 | SEC↗ |
| Semba Charles Pauling | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 16,968 | — | $0 | 16,968 | SEC↗ |
| Pauls Dietrich John | President and CEO | A Award deriv | 2023-06-01 | 2023-06-02 | 181,000 | — | $0 | 181,000 | SEC↗ |
| Kellen Scott | CFO and Secretary | A Award deriv | 2023-06-01 | 2023-06-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Gruis Kirsten L | Chief Medical Officer | A Award deriv | 2023-06-01 | 2023-06-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Cundari Dominic R | Chief Commercial Officer | A Award deriv | 2023-06-01 | 2023-06-02 | 27,000 | — | $0 | 27,000 | SEC↗ |
| Daves Julie VanOrsdel | SVP Clinical Development Ope | A Award deriv | 2023-06-01 | 2023-06-02 | 54,000 | — | $0 | 54,000 | SEC↗ |
| Kuntz Richard | Director | A Award deriv | 2023-05-30 | 2023-05-30 | 32,320 | — | $0 | 32,320 | SEC↗ |
| Wambeke David J. | Chief Business Officer | A Award deriv | 2023-04-10 | 2023-04-11 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Wambeke David J. | Chief Business Officer | P Buy | 2023-04-10 | 2023-04-11 | 468,750 | $1.60 | $750.0K | 468,750 | SEC↗ |
| Lewis Tanya | Director | A Award deriv | 2023-03-01 | 2023-03-06 | 26,443 | — | $0 | 26,443 | SEC↗ |
| Pilnik Richard D. | Director | A Award | 2023-01-03 | 2023-01-03 | 55,555 | $1.53 | $85.0K | 209,882 | SEC↗ |
| Semba Charles Pauling | Director | A Award | 2023-01-03 | 2023-01-03 | 17,156 | $1.53 | $26.2K | 17,156 | SEC↗ |
| Burroughs Amy L. | Director | A Award | 2023-01-03 | 2023-01-03 | 17,156 | $1.53 | $26.2K | 73,288 | SEC↗ |
| Giuffre Randall Michael | Director | A Award | 2023-01-03 | 2023-01-03 | 35,130 | $1.53 | $53.7K | 295,355 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2022-12-09 | 2022-12-12 | 37,079 | $1.43 | $53.0K | 260,225 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2022-12-08 | 2022-12-12 | 20,000 | $1.40 | $28.0K | 223,146 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2022-12-07 | 2022-12-08 | 22,574 | $1.40 | $31.6K | 203,146 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2022-12-06 | 2022-12-08 | 2,300 | $1.35 | $3.1K | 180,572 | SEC↗ |
| Pilnik Richard D. | Director | P Buy | 2022-12-05 | 2022-12-05 | 35,000 | $1.39 | $48.6K | 154,327 | SEC↗ |
| Von Koch Thomas | 10% Owner | S Sale | 2022-12-02 | 2022-12-06 | 2,855,847 | $1.24 | $3.54M | 0 | SEC↗ |
| Von Koch Thomas | 10% Owner | P Buy | 2022-12-02 | 2022-12-06 | 2,855,847 | $1.24 | $3.54M | 2,855,847 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2022-12-01 | 2022-12-01 | 46,133 | $1.20 | $55.4K | 177,453 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2022-12-01 | 2022-12-05 | 819 | $1.19 | $975 | 178,272 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2022-11-30 | 2022-12-01 | 2,970 | $1.19 | $3.5K | 131,320 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2022-11-29 | 2022-12-01 | 18,125 | $1.19 | $21.6K | 128,350 | SEC↗ |
| Daves Julie VanOrsdel | SVP Clinical Development Ope | A Award deriv | 2022-09-13 | 2022-09-15 | 140,000 | — | $0 | 140,000 | SEC↗ |
| TomEnterprise AB | 10% Owner | P Buy | 2022-07-08 | 2022-07-21 | 207,974 | $1.33 | $276.6K | 2,855,827 | SEC↗ |
| Semba Charles Pauling | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 13,222 | — | $0 | 13,222 | SEC↗ |
| Pilnik Richard D. | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 18,510 | — | $0 | 18,510 | SEC↗ |
| Parsons James T. | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 13,222 | — | $0 | 13,222 | SEC↗ |
| Giuffre Randall Michael | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 13,222 | — | $0 | 13,222 | SEC↗ |
| Burroughs Amy L. | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 13,222 | — | $0 | 13,222 | SEC↗ |
| Kellen Scott | CFO and Secretary | A Award deriv | 2022-06-01 | 2022-06-02 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Pauls Dietrich John | President and CEO | A Award deriv | 2022-06-01 | 2022-06-02 | 177,000 | — | $0 | 177,000 | SEC↗ |
| Cundari Dominic R | Chief Commercial Officer | A Award deriv | 2022-02-01 | 2022-02-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Cundari Dominic R | Chief Commercial Officer | A Award deriv | 2022-02-01 | 2022-02-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Gruis Kirsten L | Chief Medical Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Giuffre Randall Michael | Director | A Award | 2022-01-03 | 2022-01-03 | 15,026 | $3.58 | $53.8K | 110,225 | SEC↗ |
| Parsons James T. | Director | A Award | 2022-01-03 | 2022-01-03 | 16,773 | $3.58 | $60.0K | 38,509 | SEC↗ |
| Pilnik Richard D. | Director | A Award | 2022-01-03 | 2022-01-03 | 23,762 | $3.58 | $85.1K | 119,327 | SEC↗ |
| Burroughs Amy L. | Director | A Award | 2022-01-03 | 2022-01-03 | 11,182 | $3.58 | $40.0K | 56,132 | SEC↗ |
| ALCORN HARRY W JR | SVP, Clinical Operations | P Buy | 2021-09-15 | 2021-09-15 | 15,000 | $3.80 | $57.0K | 43,582 | SEC↗ |
| Kellen Scott | CFO and Secretary | P Buy | 2021-08-16 | 2021-08-16 | 10,000 | $3.15 | $31.5K | 22,290 | SEC↗ |
| Pauls Dietrich John | President and CEO | P Buy | 2021-08-16 | 2021-08-16 | 5,000 | $3.14 | $15.7K | 35,804 | SEC↗ |
| ALCORN HARRY W JR | Senior VP, Clinical Operatio | P Buy | 2021-08-16 | 2021-08-16 | 20,000 | $3.09 | $61.8K | 28,260 | SEC↗ |
| ALCORN HARRY W JR | Senior VP, Clinical Operatio | P Buy | 2021-08-16 | 2021-08-16 | 322 | $3.06 | $985 | 28,582 | SEC↗ |
| ALCORN HARRY W JR | Senior VP, Clinical Operatio | P Buy | 2021-08-16 | 2021-08-16 | 399 | $3.07 | $1.2K | 399 | SEC↗ |
| Pilnik Richard D. | Director | P Buy | 2021-08-16 | 2021-08-17 | 2,500 | $3.21 | $8.0K | 83,065 | SEC↗ |
| Pilnik Richard D. | Director | P Buy | 2021-08-16 | 2021-08-17 | 12,500 | $3.28 | $41.0K | 95,565 | SEC↗ |
| Burroughs Amy L. | Director | P Buy | 2021-08-16 | 2021-08-17 | 44,950 | $3.15 | $141.6K | 44,950 | SEC↗ |
| Kellen Scott | CFO and Secretary | A Award deriv | 2021-07-28 | 2021-07-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Pauls Dietrich John | President and CEO | A Award deriv | 2021-07-28 | 2021-07-29 | 175,000 | — | $0 | 175,000 | SEC↗ |
| ALCORN HARRY W JR | Chief Medical Officer | A Award deriv | 2021-07-28 | 2021-07-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Gilman Sydney A. | VP, Regulatory Affairs | A Award deriv | 2021-07-28 | 2021-07-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Semba Charles Pauling | Director | A Award deriv | 2021-07-15 | 2021-07-16 | 18,786 | — | $0 | 18,786 | SEC↗ |
| Burroughs Amy L. | Director | A Award deriv | 2021-07-15 | 2021-07-16 | 18,786 | — | $0 | 18,786 | SEC↗ |
| Pilnik Richard D. | Director | A Award deriv | 2021-07-15 | 2021-07-16 | 13,150 | — | $0 | 13,150 | SEC↗ |
| Parsons James T. | Director | A Award deriv | 2021-07-15 | 2021-07-16 | 9,393 | — | $0 | 9,393 | SEC↗ |
| Giuffre Randall Michael | Director | A Award deriv | 2021-07-15 | 2021-07-16 | 9,393 | — | $0 | 9,393 | SEC↗ |
| Pilnik Richard D. | Director | A Award | 2021-01-01 | 2021-01-04 | 9,719 | $8.23 | $80.0K | 80,565 | SEC↗ |
| Parsons James T. | Director | A Award | 2021-01-01 | 2021-01-04 | 7,745 | $8.23 | $63.7K | 21,947 | SEC↗ |
| Giuffre Randall Michael | Director | A Award | 2021-01-01 | 2021-01-04 | 7,441 | $8.23 | $61.2K | 116,029 | SEC↗ |
| Pilnik Richard D. | Director | P Buy | 2020-12-04 | 2020-12-04 | 5,000 | $5.50 | $27.5K | 65,846 | SEC↗ |
| Pilnik Richard D. | Director | P Buy | 2020-12-04 | 2020-12-04 | 5,000 | $5.24 | $26.2K | 70,846 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2020-11-20 | 2020-11-23 | 15,000 | $4.26 | $63.9K | 108,588 | SEC↗ |
| Kellen Scott | CFO and Secretary | P Buy | 2020-11-09 | 2020-11-10 | 2,000 | $4.19 | $8.4K | 12,290 | SEC↗ |
| Pilnik Richard D. | Director | A Award deriv | 2020-06-01 | 2020-06-02 | 19,220 | — | $0 | 19,220 | SEC↗ |
| Parsons James T. | Director | A Award deriv | 2020-06-01 | 2020-06-02 | 13,306 | — | $0 | 13,306 | SEC↗ |
| Giuffre Randall Michael | Director | A Award deriv | 2020-06-01 | 2020-06-02 | 13,306 | — | $0 | 13,306 | SEC↗ |
| ALCORN HARRY W JR | Chief Medical Officer | A Award deriv | 2020-06-01 | 2020-06-02 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Pauls Dietrich John | President and CEO | A Award deriv | 2020-06-01 | 2020-06-02 | 56,000 | — | $0 | 56,000 | SEC↗ |
| Kellen Scott | CFO and Secretary | A Award deriv | 2020-06-01 | 2020-06-02 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Gilman Sydney A. | VP, Regulatory Affairs | A Award deriv | 2020-06-01 | 2020-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Pilnik Richard D. | Director | A Award | 2020-06-01 | 2020-06-02 | 10,168 | $4.59 | $46.7K | 60,846 | SEC↗ |
| Parsons James T. | Director | A Award | 2020-06-01 | 2020-06-02 | 8,102 | $4.59 | $37.2K | 14,202 | SEC↗ |
| Giuffre Randall Michael | Director | A Award | 2020-06-01 | 2020-06-02 | 7,784 | $4.59 | $35.7K | 93,588 | SEC↗ |
| Gilman Sydney A. | VP, Regulatory Affairs | A Award deriv | 2019-11-01 | 2019-11-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Kellen Scott | CFO and Secretary | P Buy | 2019-08-19 | 2019-08-19 | 3,000 | $2.43 | $7.3K | 10,290 | SEC↗ |
| Pauls Dietrich John | President and CEO | P Buy | 2019-08-16 | 2019-08-16 | 1,000 | $2.68 | $2.7K | 30,804 | SEC↗ |
| ALCORN HARRY W JR | Chief Medical Officer | P Buy | 2019-08-16 | 2019-08-16 | 7,260 | $2.67 | $19.4K | 8,260 | SEC↗ |
| Pilnik Richard D. | Director | P Buy | 2019-08-16 | 2019-08-19 | 7,840 | $2.56 | $20.1K | 50,678 | SEC↗ |
| ALCORN HARRY W JR | Chief Medical Officer | A Award deriv | 2019-06-24 | 2019-06-26 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Giuffre Randall Michael | Director | A Award deriv | 2019-06-24 | 2019-06-26 | 12,950 | — | $0 | 12,950 | SEC↗ |
| Kellen Scott | CFO and Secretary | A Award deriv | 2019-06-24 | 2019-06-26 | 99,750 | — | $0 | 99,750 | SEC↗ |
| Parsons James T. | Director | A Award deriv | 2019-06-24 | 2019-06-26 | 12,950 | — | $0 | 12,950 | SEC↗ |
| Pauls Dietrich John | President and CEO | A Award deriv | 2019-06-24 | 2019-06-26 | 264,000 | — | $0 | 264,000 | SEC↗ |
| Pilnik Richard D. | Director | A Award deriv | 2019-06-24 | 2019-06-26 | 18,700 | — | $0 | 18,700 | SEC↗ |
| Verdoorn Todd A. | Chief Scientific Officer | A Award deriv | 2019-06-24 | 2019-06-26 | 71,025 | — | $0 | 71,025 | SEC↗ |
| Xiao Zhenyu | Director | A Award deriv | 2019-06-24 | 2019-06-26 | 12,950 | — | $0 | 12,950 | SEC↗ |
| Pilnik Richard D. | Director | P Buy | 2019-05-31 | 2019-05-31 | 19,000 | $2.80 | $53.2K | 42,838 | SEC↗ |
| Kellen Scott | CFO and Secretary | P Buy | 2019-05-24 | 2019-05-28 | 4,000 | $2.94 | $11.8K | 7,290 | SEC↗ |
| ALCORN HARRY W JR | Chief Medical Officer | G Gift | 2019-03-28 | 2019-03-29 | 150 | — | $0 | 1,000 | SEC↗ |
| ALCORN HARRY W JR | Chief Medical Officer | P Buy | 2019-03-27 | 2019-03-29 | 150 | $4.46 | $669 | 1,150 | SEC↗ |
| ALCORN HARRY W JR | Chief Medical Officer | P Buy | 2018-12-11 | 2018-12-11 | 1,000 | $4.00 | $4.0K | 1,000 | SEC↗ |
| Giuffre Randall Michael | Director | P Buy | 2018-12-11 | 2018-12-11 | 11,250 | $4.00 | $45.0K | 85,804 | SEC↗ |
| Kellen Scott | CFO and Secretary | P Buy | 2018-12-11 | 2018-12-11 | 1,250 | $4.00 | $5.0K | 3,290 | SEC↗ |
| Parsons James T. | Director | P Buy | 2018-12-11 | 2018-12-11 | 2,250 | $4.00 | $9.0K | 6,100 | SEC↗ |
| Pauls Dietrich John | President and CEO | P Buy | 2018-12-11 | 2018-12-11 | 5,000 | $4.00 | $20.0K | 29,804 | SEC↗ |
| Pilnik Richard D. | Director | P Buy | 2018-12-11 | 2018-12-11 | 6,250 | $4.00 | $25.0K | 23,838 | SEC↗ |
| Verdoorn Todd A. | Chief Scientific Officer | P Buy | 2018-12-11 | 2018-12-11 | 1,000 | $4.00 | $4.0K | 2,000 | SEC↗ |
| Xiao Zhenyu | Director, 10% Owner | P Buy | 2018-12-11 | 2018-12-11 | 3,250 | $4.00 | $13.0K | 7,100 | SEC↗ |